bioAffinity Technologies, Inc. (BIAF)
BIAF Stock Price Chart
Explore bioAffinity Technologies, Inc. interactive price chart. Choose custom timeframes to analyze BIAF price movements and trends.
BIAF Company Profile
Discover essential business fundamentals and corporate details for bioAffinity Technologies, Inc. (BIAF) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Medical - Diagnostics & Research
IPO Date
1 Sept 2022
Employees
57.00
Website
https://www.bioaffinitytech.comCEO
Maria Zannes
Description
bioAffinity Technologies, Inc., a biotechnology company, engages in developing non-invasive diagnostic tests and targeted cancer therapeutics. The company offers CyPath lung, a diagnostic test, for early detection of lung cancer. It also researches targeted therapies to treat cancer at the cellular level. The company was founded in 2014 and is based in San Antonio, Texas.
BIAF Financial Timeline
Browse a chronological timeline of bioAffinity Technologies, Inc. corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 13 May 2026
Upcoming earnings on 12 Nov 2025
Earnings released on 14 Aug 2025
EPS came in at -$0.13 falling short of the estimated -$0.09 by -44.44%, while revenue for the quarter reached $1.27M , missing expectations by -10.03%.
Earnings released on 15 May 2025
EPS came in at -$0.16 matching the estimated -$0.16, while revenue for the quarter reached $1.85M , beating expectations by +53.73%.
Earnings released on 31 Mar 2025
EPS came in at -$0.21 falling short of the estimated -$0.14 by -50.00%, while revenue for the quarter reached $2.21M , missing expectations by -8.68%.
Earnings released on 14 Nov 2024
EPS came in at -$0.16 falling short of the estimated -$0.15 by -6.67%, while revenue for the quarter reached $2.35M , missing expectations by -7.44%.
Earnings released on 14 Aug 2024
EPS came in at -$0.19 falling short of the estimated -$0.17 by -11.76%, while revenue for the quarter reached $2.40M , missing expectations by -2.16%.
Earnings released on 15 May 2024
EPS came in at -$0.21 falling short of the estimated -$0.15 by -40.00%, while revenue for the quarter reached $2.41M , missing expectations by -5.28%.
Earnings released on 1 Apr 2024
EPS came in at -$0.26 falling short of the estimated -$0.20 by -30.00%, while revenue for the quarter reached $2.21M , beating expectations by +22.94%.
Earnings released on 14 Nov 2023
EPS came in at -$0.26 falling short of the estimated -$0.18 by -44.44%, while revenue for the quarter reached $298.48K , beating expectations by +198.48%.
Earnings released on 14 Aug 2023
EPS came in at -$0.20 falling short of the estimated -$0.13 by -53.85%, while revenue for the quarter reached $19.74K .
Earnings released on 15 May 2023
EPS came in at -$0.18 surpassing the estimated -$0.21 by +14.29%, while revenue for the quarter reached $921.00 , missing expectations by -99.08%.
Earnings released on 31 Mar 2023
EPS came in at -$0.20 falling short of the estimated -$0.19 by -5.16%, while revenue for the quarter reached $2.35K .
Earnings released on 14 Nov 2022
EPS came in at -$1.10 , while revenue for the quarter reached $1.15K .
Earnings released on 2 Sept 2022
EPS came in at -$0.03 , while revenue for the quarter reached $1.31K .
Earnings released on 31 Mar 2022
EPS came in at -$0.54 .
Earnings released on 31 Dec 2021
EPS came in at -$2.04 .
Earnings released on 30 Sept 2021
EPS came in at -$0.55 .
Earnings released on 30 Jun 2021
EPS came in at $0.54 .
Earnings released on 31 Mar 2021
EPS came in at -$0.26 .
Earnings released on 31 Dec 2020
EPS came in at -$0.80 .
BIAF Stock Performance
Access detailed BIAF performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.